(Q73290174)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11113716%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Serum erythropoietin in heart failure patients treated with ACE-inhibitors or AT(1) antagonists (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11113716%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

B Chatterjee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11113716%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

U E Nydegger

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11113716%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Mohacsi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11113716%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11113716%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Heart Failure

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11113716%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11113716%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11113716%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

393-398

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11113716%20AND%20SRC:MED&resulttype=core&format=json

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Erythropoietin treatment does not compromise cardiovascular function in chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: any evidence of erythropoietin resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Improving outcomes in congestive heart failure: Val-HeFT. Valsartan in Heart Failure Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Worsening of anemia induced by long-term use of captopril in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Enalapril-associated anemia in renal transplant recipients treated for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Angiotensin-converting enzyme inhibitor and anemia in a patient undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Role of erythropoietin in pathogenesis of post transplant erythrocytosis (PTE) and mechanism of losartan's efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Losartan, an angiotensin-II receptor antagonist, reduces hematocrits in kidney transplant recipients with posttransplant erythrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Angiotensin-converting enzyme inhibitors but not angiotensin II AT 1 receptor antagonists affect erythropoiesis in patients with anemia of end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Losartan and anaemia of end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

High serum erythropoietin levels are normalized during treatment of congestive heart failure with enalapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Elevated level of erythropoietin in congestive heart failure relationship to renal perfusion and plasma renin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Erythropoietin receptor mRNA expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Effect of erythropoietin on DNA synthesis, proto-oncogene expression and phospholipase C activity in rat vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Signal transduction of erythropoietin in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Erythropoietin modified the cardiac action of ouabain in chronically anaemic-uraemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Recombinant human erythropoietin enhances vasoconstrictor tone via endothelin-1 and constrictor prostanoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Treatment with recombinant human erythropoietin induces a moderate rise in hematocrit and thrombin antithrombin in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Erythropoietin receptor-operated Ca2+ channels: activation by phospholipase C-gamma 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

The heterogeneity of circulating human serum erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Effect of increased hemodialysis dose on endogenous erythropoietin production in end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Effects of ACE inhibitor on renal anemia in predialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Haemoglobin--is more better?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Are current methods of measurement of erythropoietin (EPO) in human plasma or serum adequate for the diagnosis of polycythaemia vera and the assessment of EPO deficiency?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Serum erythropoietin concentration in anaemia of visceral leishmaniasis (kala-azar) before and during antimonial therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Do ACE inhibitors influence the dose of human recombinant erythropoietin in dialysis patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

Worsening of anemia by angiotensin converting enzyme inhibitors and its prevention by antiestrogenic steroid in chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Angiotensin-II, renal anemia and hyporesponsiveness to recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900110-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S1388-9842(00)00110-0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11113716%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference